Research and Development

Showing 15 posts of 9626 posts found.

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026 Research and Development interstitial lung disease

Serac Healthcare has presented phase 2 data suggesting its investigational imaging agent, 99mTc-maraciclatide, may help distinguish active inflammation from fibrosis …

Laverock secures funding for gene-control platform development

June 4, 2026 Research and Development Laverock Therapeutics

Laverock Therapeutics has been awarded more than £2.2m in grant funding to support development of its gene-control platform and expand …

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026 Research and Development gene therapies

LifeArc has announced a partnership with Elpida Therapeutics to support development of gene therapies for three ultra-rare neurodegenerative diseases affecting …

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026 Research and Development dementia

Well Pharmacy has announced a partnership with Alzheimer’s Society aimed at improving support for people living with dementia and their …
drug-trials

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026 Research and Development donidalorsen

Otsuka Pharmaceuticals UK announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Dawnzera (donidalorsen) for routine prevention …

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026 Research and Development BioDuro, CTI Biotechnology

BioDuro has announced a strategic partnership with CTI Biotechnology. The collaboration will leverage the complementary strengths of both companies across critical stages …

Study explores genomic testing approach for unexplained infertility

May 14, 2026 Research and Development infertility

Researchers across the Asia Pacific region have reported findings from a study investigating whether long-read whole genome sequencing could improve …

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026 Research and Development Sophia Genetics, Synnovis

Synnovis and SOPHiA GENETICS have announced a collaboration to expand blood-based cancer testing for patients with lung and breast cancer …

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026 Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Maninder Kapoor Puri as …

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026 Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Abhijit Zutshi as Chief …

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026 Research and Development fatty liver disease, phospholipid therapy

A randomised clinical trial has reported that treatment with essential phospholipids (Essentiale) may reduce liver fat and improve symptoms in …

New web series explores path from ophthalmic research to patient access

April 28, 2026 Research and Development Opthalmology

A new YouTube web series has been launched to examine how ophthalmic innovations progress from early research through to approved …

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026 Research and Development The European Medicines Agency (EMA), plozasiran

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Redemplo (plozasiran) to treat adults with familial chylomicronaemia …

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026 Research and Development SynaptixBio, neurodegenerative disease

SynaptixBio has highlighted the potential of speech analysis as a non-invasive way to track disease progression in neurodegenerative conditions, as …

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026 Research and Development RWS, kayentis

Kayentis and RWS have announced a partnership aimed at improving confidence in clinical trial data for neuroscience and other complex …
The Gateway to Local Adoption Series

Latest content